NY Sues Illumina Board Over ‘Disastrous’ $8 Billion Grail Deal

Aug. 26, 2024, 2:47 PM UTC

New York’s public pensions have joined widening shareholder litigation over the costly consequences of Illumina Inc.'s failed $8 billion bid to buy cancer-detection startup Grail Inc., which was rejected by regulators.

State Comptroller Thomas DiNapoli is suing Illumina board members on behalf of two retirement funds, saying they recklessly rushed into the doomed deal with full knowledge they were violating a European regulation requiring companies to pause mergers while they’re reviewed on antitrust grounds.

The move “ignited legal chaos,” the lawsuit says, pointing to hundreds of millions in fines, billions in lost value, the June 2023 resignation of Illumina ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.